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A patient with coexistent hemochromatosis and alpha-I-antitrypsin deficiency which led to 
cirrhosis and death despite adequate therapy for hemOchromatosis is reported. Evaluation of the 
family revealed first degree relatives with iron overload and others with alpha-I-antitrypsin 
deficiency but none with both conditions. The role of family studies in the early recognition and 
possible prevention of overt clinical disease in individuals with either of these two genetic diseases 
is discussed. 
The term hemochromatosis has been broadened re-
cently to include disorders with a similar clinicopatho-
logical picture which result in a progressive increase in 
total body iron and deposition of iron in hepatic, pan-
creatic, myocardial, and hypothalamic parenchymal cells 
(1). The idiopathic variety of hemochromatosis (primary 
hemochromatosis) is a genetically inherited autosomal 
recessive disorder linked to the presence of certain his-
tocompatibility antigens (HLA A3; B7 and BI4) (2). The 
incidence of iron overload in first degree relatives of 
index cases is reported to be 15% (3). The recognition of 
this association has permitted detection of the abnor-
mality in closely related family members of individuals 
known to have the disease by demonstrating an HLA 
haplotype in the individual at risk similar to that of the 
proband (4). 
Secondary hemochromatosis like primary hemochro-
matosis also occurs in families but is not associated with 
a common HLA haplotype and is not due solely to 
excessive iron absorption. Instead, secondary hemochro-
matosis has been shown to occur in thalassemia major, 
sideroblastic anemia, alcoholic cirrhosis, and following 
portocaval shunting and prolonged excessive iron inges-
tion (1). 
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Alpha -I-antitrypsin (AA T) is a plasma glycoprotein 
which functions as a protease inhibitor. The AA T alleles 
are inherited in an autosomal codominant manner, and 
the deficiency state is inherited in an autosomal recessive 
manner with heterozygotes expressing the phenotype 
when provoked, such as by cigarette smoking (5). AAT 
deficiency is partially understood with 26 different alleles 
presently recognized by isoelectric focusing. The most 
common is Pi MM (homozygous Pi'M allele) which 
results in normal AA T levels. AA T deficiency usually is 
associated with either Pi ZZ, Pi SZ, or Pi Null haplotypes. 
The presence of these genotypes results in plasma en-
zyme deficiency and occasionally liver disease which can 
progress to cirrhosis (6). In contrast, Pi, MZ, the com-
monest heterozygous state, is usually not associated with 
clinical disease. Recently, however, an increased preva-
lence of the heterozygous state has been reported in 
patients with cryptogenic cirrhosis and chronic active 
hepatitis (7). The reported incidence of the genotype Pi 
ZZ in the general population is 0.13% and that of the 
genotype Pi MZ is 2.74% (8). 
Here, we report an individual with both AA T defi-
ciency and primary hemochromatosis who developed pro-
gressive liver disease despite adequate therapy for hem-
ochromatosis. In evaluation of the family, relatives with 
one or the other, but not both, diseases were identified. 
CASE HISTORY OF THE PROBAND 
P. M. was a 42-year-old white male referred for possi-
ble liver transplantation. His medical history b~gan :n 
1976 when a routine annual physical and laboratory 
exam showed abnormal enzymes (hypertransaminase-
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mia). Additional investiga:tions included a normal oral 
cholescytogram, normal liver scan, and negative hepatitis 
B serology. After 6 months of persistently elevated serum 
enzyme levels, he underwent a percutaneous liver biopsy. 
The biopsy was interpreted as showing the presence of 
abundant iron pigment in hepatocytes, mild portal fibro-
sis but no cirrhosis. Subsequently his serum iron was 
found to be elevated (283 .ug%; n = 42 to 135) with a 
transferrin saturation of 100% (n = 20 to 40%). A "des-
ferroxamine test" showed an iron excretion of 6.9 mg per 
24 hr in the urine (n < 0.15 mg per 24 hr), and a glucose 
tolerance test documented chemical diabetes mellitus 
and glycosuria_ A diagnosis of hemochromatosis was 
made, and he was placed on weekly phlebotomy. In 
January, 1978, after 60 units of blood had been removed, 
his serum iron was 317 .ug with 90% transferrin satura-
tion. Phlebotomy was increased to biweekly and in July, 
1978, after removal of approximately 37 mg of stored 
iron, his serum iron was reduced to 8 .ug% and his 
transferrin saturation was reduced to 2.5%. 
He did well with continued monthly phlebotomy and 
maintained normal to low serum iron and transferrin 
saturation levels. In October, 1981, he reported increas-
ing fatigue, increasing abdominal girth, and was admitted 
to the hospital for further diagnostic study. For the first 
time he had abnormal liver function (bilirubin 4.9 mg 
per dl, protime 17.5 sec per 11 sec control and an albumin 
level of 3.2 gm per dl). In addition, he demonstrated 
elevated serum enzyme levels (SGOT, 115 IU per liter; 
SGPT, 42 IU per liter; alkaline phosphatase, 134 IU per 
liter). A diagnosis of cirrhosis presumably due to hemo-
chromatosis with portal hypertension was made on clin-
ical grounds and confirmed on liver biopsy (Figure 1C). 
His subsequent course was rapidly progressive with nu-
merous episodes of spontaneous bacterial peritonitis, 
sepsis, variceal bleeding, and development of the hepa-
torenal syndrome. 
He was transferred to the Presbyterian-University 
Hospital for consideration for a liver transplant. Perti-
nent additional past history revealed no transfusions, no 
hepatitis exposure, no alcohol abuse, and no family his-
tory of pulmonary or hepatic disease. On physical ex-
amination, he was alert and cooperative but obviously 
ill. He had stigmata of chronic liver disease including 
spider angiomata, decreased body hair, and asterixis. He 
was jaundiced and had a large right pleural effusion, 
ascites, and a caput medussa but no clinically apparent 
splenomegaly. The liver was firm, 4 cm below the right 
costal margin in the midclavicular line. He had bilateral 
testicular atrophy. In addition, he had guaiac positive 
melanic stool. 
Additional investigations documented an AAT level of 
36 mg per dl (nl = 85 to 213), a homozygous ZZ phenotype 
and HLA antigens AI, 25; B8, 18; and Dr 3,4, suggesting 
a diagnosis of homozygous AA T deficiency in addition 
to primary hemochromatosis. The progression of his liver 
disease to cirrhosis and his clinical deterioration in spite 
of adequate therapy for hemochromatosis suggested that 
AA T deficiency was the underlying cause of his progres-
sive liver disease. 
He received an orthotopic liver transplant 1 month 
after admission. Severe early rejection and a stormy 
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postoperative course resulted in death. Autopsy con-
firmed iron overload in the pancreas, testes, spleen, 
heart, and pituitary. Pathologic examination of the pa-
tient's original liver demonstrated evidence of both iron 
overload and AA T deficiency in addition to advanced 
cirrhosis (Figure 1). 
FAMILY STUDY 
A study of 11 immediate family members was per-
formed including testing for histocompatibility antigens, 
serum iron, TIBC, transferrin saturation, serum ferritin, 
and AA T phenotyping and quantitation. 
MATERIALS AND METHODS 
HLA typing was performed using the modified cyto-
toxicity method of Amos (9). Serum iron was measured 
after incubation with ascorbic and hydrochloric acid to 
liberate protein bound iron (10). Total iron binding ca-
pacity was measured by saturation of the serum with 
ferric iron followed by removal of excess iron with mag-
nesium carbonate and then determining the amount of 
iron bound to protein (11). Serum ferritin was measured 
utilizing the immunoradiometric assay initially described 
by Addison et al. (12). AAT phenotyping was accom-
plished by isoelectric focusing on polyacrylamide gel 
using established methods and known standards (13). 
The surgical and autopsy specimens were fixed in 10% 
formaIin. Sections from the hepatectomy specimen were 
stained with hematoxylin and eosin, Prussian blue re-
agent for iron, periodic acid-Schiff reagent with and 
without diastase treatment, orcein method for hepatitis 
B antigen, and Hall's method for bilirubin. Paraffin 
blocks from the referring hospital were obtained, and the 
above special stains were performed on these specimens. 
Representative formalin-fixed, paraffin-embedded sec-
tions were immuno-stained using the peroxidase antiper-
oxidase technique (14). Specific antiserum against AAT 
was employed. All antibodies used were commercially 
available from ADKO (Accurate Chemical and Scientific 
Co., Hicksville, NY). Substitution of the primary anti-
body by saline solution and liver tissue from known cases 
of AA T deficiency were simultaneously used as controls. 
RESULTS 
The results of the family study are shown in Figure 2. 
AA T is seen clearly to be inherited as an autosomal 
codominant disease with the quantitative level of this 
plasma protein being dependent on the number of Z 
alleles present in an individual. The proband (Paul) 
married a heterozygote (Carol) and had two offspring, 
both carrying the ZZ phenotype. Both these offspring, 
although asymptomatic, have low AA T levels. 
The presence of significant iron overload was detected 
in only one family member (Stephen) other than the 
proband. The well-documented HLA markers for hemo-
chromatosis (HLA A3; B14) were not seen in this family. 
In contrast, the HLA B7 antigen was present in five 
family members. The two members with documented 
iron overload shared two common HLA alleles (HLA Al 
and B8). Several other family members, Thomas, Daniel, 
and Stephen, all in the third generation in Figure 2, also 
have these alleles. It should be noted, however, that 
FIG. 1. (Al Photomicrograph of original liver biopsy on which the diagnoses of hemachromatosis and cirrhosis were made. Note iron (black 
pigment) in hepatocytes and bile duct. Prussian blue, x 193. (B) Photomicrograph of liver removed at time of liver transplant which demonstrated 
only minimal iron (arrows) in bile ductules and hepatocytes. Pruss ian blue, x 193. (e) Photomicrograph of liver removed at time of liver 
transplant which demonstrated positive immunoperoxidase staining (black pigment) for AAT in hepatocytes. Note most densely stained 
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ELIZABETH 41 
THOMAS 17 DANIEL 15 
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43% 28% 
IRENE 71 
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19% 
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BETH ANN 7 
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ZZ 
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29mg% 
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KEY 
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CAROL 41 
MAURAI5 
90% SATURATION IN 1978 AFTER 60 UNITS OF BLOOD 
REMOVED BY PHLEBOTOMY 
FIG. 2. Family tree of proband (marked by dark square in second row) and his family. Results of special studies performed on family members 
are presented for each member as shown by the key in the right upper corner of the figure. 
Daniel inherited the Al B8 haptotypes from his mother 
(Elizabeth), not his father (David), Three of these chil-
dren also possess the HLA B7 antigen inherited from 
their mother and are therefore possibly at risk for iron 
overloading (presently negative). 
DISCUSSION 
To our knowledge, there are no reported cases in the 
English literature of (AA T) deficiency and idiopathic 
hemochromatosis in the same patient and in the same 
family. The prevalence of the homozygous AAT defi-
ciency state (Pi ZZ) is reported to be 0.13% and that of 
the heterozygous deficiency state (Pi MZ) to be 2.74 % as 
determined in a group of patients evaluated for lung 
disease (8). As might be expected, autopsy series report 
a somewhat higher figure for the prevalence (6.3%) of 
the Pi Z allele (15). 
In general the expression of AA T deficiency is inher-
ited as an autosomal codominant trait as seen in the 
present family (5). Both parents of our proband were 
heterozygotic for the Z allele. Interestingly, this combi-
nation has been reported to be associated with a higher 
incidence of offspring who are homozygotic for the Z 
.allele than would be expected otherwise by simple Men-
delian genetics (16). 
Unfortunately, our proband married a heterozygote 
(Pi SZ) and had two homozygotic (Pi ZZ) offspring 
(Figure 2). Again, following a classical pattern of codom-
inant genetic expression, quantitative AAT levels in the 
homozygotes (Pi ZZ) were about one-quarter those seen 
in normals (Pi MM). The homozygotes are at definite 
risk for developing clinical pulmonary and/or hepatic 
disease, and heterozygotes are at a somewhat smaller 
risk of developing clinical disease, especially if other 
cofactors are present (17). 
Early diagnosis of such a condition in a specific indi-
vidual can be quite difficult and is made considerably 
easier when based upon data obtained from a family 
study. Once detected, immediate careful testing for occult 
disease in family members is mandatory, and the initia-
tion of preventive measures to either reduce the morbid-
ity or prevent the expression of disease can be instituted. 
For example, abstinence from smoking has been estab-
lished to be clearly useful (17) and abstinence from 
alcohol might be prudent, although not established in 
such individuals. Further, genetic counseling is impor-
tant, especially pertaining to the likelihood of bearing 
children with AAT deficiency (18, 19). 
The proband in our study had good evidence for the 
diagnosis of idiopathic hemochromatosis documented by 
the extreme amounts of parenchymal iron demonstrated 
by both pathologic (4+ staining with Prussian blue) and 
biochemical data (approximately 37 gm of iron removed 
by phlebotomy without development of anemia). The 
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fact that the proband had continued progression of liver 
disease in spite of active phlebotomy therapy suggested 
that a second condition might be present. Based upon 
such reasoning, other causes for progressive liver disease 
were investigated and AA T deficiency was discovered. 
The HLA alleles (A3, B7, and B) classically linked 
with hemochromatosis (2) were not found in this family 
except in the wife of the proband (Carol) (Figure 2). In 
this regard, it has been shown previously that the pres-
ence of hemochromatosis in family members of a proband 
is not linked solely to the presence of these specific HLA 
alleles, but is linked to the possession of a similar HLA 
haplotype as is present in the proband (3, 20, 21). In the 
present family, six members share the same HLA hap-
lotype (AI, B8) as the proband (Figure 2) and might 
therefore be hemochromatosis heterozygotes. One (Ste-
phen in the first generation) is clearly iron overloaded. 
Four others (all in the third generation) are not presently 
iron overloaded but are too young to conclusively exclude 
the disease (3). One adult member in the second gener-
ation (David), although possessing the same (AI, B8) 
haplotype as the proband, has no evidence for iron ov-
erloading and presumably is a heterozygote. It should be 
noted, however, that five family members have the HLA 
B7 (all in the second and third generation, Figure 2) and 
that one (Carol) has both the A3 and B7 antigens and 
may also be heterozygous for hemochromatosis. It must 
be remembered, however, that both haplotypes are not 
uncommon in the population at large (28.4M and 25.8M, 
respectively) and each may occur in the absence of the 
hemochromatosis antigen. 
Liver transplantation has been shown to correct the 
metabolic defect in AAT deficiency, and as in our case, 
results in the conversion of the patients' phenotype from 
ZZ to MM after successful transplantation (22). 
In conclusion, we have presented a unique association 
of two distinct genetic disorders coexisting in the same 
individual and occurring in other members of his family. 
At this time, there seems to be no evidence to believe or 
suspect that the two diseases are genetically linked. 
Apparently, their coexistence in the proband has to be 
attributed to a rare chance event. 
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